Pharma News for June 1, 2020

pharma world

The coronavirus epidemic in the U.S. is expanding and the U.S. still has not put the necessary infrastructure in place to prevent a major second wave in the fall, former FDA Commissioner Dr. Scott Gottlieb says. He said Tennessee, Arizona, Texas, Georgia, North Carolina, Minnesota, Wisconsin and Ohio have all experienced increases in hospitalizations. (CNBC)

Online misinformation is fueling a backlash in some places against coronavirus containment strategies such as contact tracing and isolation. Some health officials have even received violent threats. (NPR)

COVID-19 has greatly reduced the number of in-office doctor’s visits, which has highlighted the need for online support programs to help patients maintain their health regimes. Luckily many doctors have incorporated online patient services, from the ability to have virtual appointments to enabling patients to have greater control over their healthcare programs. (Biopharmadive)

Reports suggest US government has selected five companies with the most promising vaccine leads to be given additional financial and infrastructure support. The five companies are Merck, AstraZeneca, Johnson & Johnson, Moderna and Pfizer. (Biopharma-reporter)

With more people than ever turning to the internet as their primary news source, and companies such as Facebook doing so little to curate its content, misinformation is flourishing. As Carl Bergstrom, a University of Washington researcher and the co-author of the misinformation guide “Calling Bulls—” has explained, the goal of the entities responsible for misinformation is to generate mass confusion. That leaves charlatans with the opportunity to sell phony cures or to sow division among the public for political purposes. (CNBC)